Search

Displaying results 11 - 13 of 13 in total
  1. Drug

    Navtemadlin

    go.drugbank.com/drugs/DB15299
    Investigational

    Navtemadlin (AMG-232) is under investigation in clinical trial NCT03041688 (MDM2 Inhibitor AMG-232 and Decitabine in Treating Patients With Relapsed, Refractory, or Newly-Diagnosed Acute Myeloid Leukemia

  2. Indication

    Myelodysplastic Syndrome

    go.drugbank.com/conditions/DBCOND0028333
    Drugs: Antilymphocyte immunoglobulin (horse) · Cedazuridine · Decitabine · Imatinib · Lenalidomide
  3. Indication

    Acute Myeloid Leukemia

    go.drugbank.com/conditions/DBCOND0029883
    Drugs: Azacitidine · Cedazuridine · Cyclophosphamide · Cytarabine · Decitabine · Doxorubicin +9 more